Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 17/20 | 0.72 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.53 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.53 |
| ▸ | CDK2 | P24941 | 3/20 | 0.53 |
| ▸ | PRKCA | P17252 | 2/20 | 0.53 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.49 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6574888 | 1.00 | CDK1 (0.72) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6574743 | 0.92 | CDK1 (0.67) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6574741 | 0.92 | CDK1 (0.67) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6574902 | 0.92 | CDK1 (0.71) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6574904 | 0.92 | CDK1 (0.71) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6576169 | 0.92 | CDK1 (0.71) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6576509 | 0.92 | CDK1 (0.71) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6578444 | 0.92 | CDK1 (0.71) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6576950 | 0.92 | CDK1 (0.71) | CDK1PDGFRACCNE1CDK2PRKCA | |
| SCHEMBL6574826 | 0.90 | CDK1 (0.65) | CDK1PDGFRACCNE1CDK2PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1153024-B1 | 2-AMINO-6-ANILINO-PURINES AND THEIR USE AS MEDICAMENTS | NOVARTIS AG (CH) | 2004-04-28 | — | — | EP | disclosed |